Category : Prebiotics

Recent research has shown the presence of gut dysbiosis related to a shift in short-chain fatty acids in patients with Parkinson’s disease (PD). Besides this, constipation is a major nonmotor feature of PD and little is known about whether probiotics and prebiotics could improve constipation in patients with PD. A recent randomized, double-blind, placebo-controlled trial, led by Dr. Emanuele Cereda…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Recent research has shown the presence of gut dysbiosis related to a shift in short-chain fatty acids in patients with Parkinson’s disease (PD). Besides this, constipation is a major nonmotor feature of PD and little is known about whether probiotics and prebiotics could improve constipation in patients with PD. A recent randomized, double-blind, placebo-controlled trial, led by Dr. Emanuele Cereda…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Previous research has shown that the gut microbiota may have a role in the pathogenesis of immune-related diseases involving chronic inflammation, such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, and others. A recent review, led by Dr. Hai Lu from the Department of Orthopedic Surgery at The Third Affiliated Hospital of Southern Medical University in Guangzhou (China), discusses the existing…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that the gut microbiota may have a role in the pathogenesis of immune-related diseases involving chronic inflammation, such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, and others. A recent review, led by Dr. Hai Lu from the Department of Orthopedic Surgery at The Third Affiliated Hospital of Southern Medical University in Guangzhou (China), discusses the existing…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Dietary fibre is a key nutrient for optimizing gut health and it has been previously documented that a fibre-deprived diet may have a negative impact on the colonic mucus layer and gut microbiota functionality. Resistant starch (RS) is a form of starch that is not digested in the small intestine and is therefore considered a type of dietary fibre.  …

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Dietary fibre is a key nutrient for optimizing gut health and it has been previously documented that a fibre-deprived diet may have a negative impact on the colonic mucus layer and gut microbiota functionality. Resistant starch (RS) is a form of starch that is not digested in the small intestine and is therefore considered a type of dietary fibre.  …

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

In a recent paper by Perry et al., researchers describe an investigation into the putative mechanisms by which gut microbiota alterations may lead to obesity, insulin resistance, and metabolic syndrome. Authors describe increased production of acetate by altered gut microbiota in rats. They link this to activation of the parasympathetic nervous system, increased glucose-stimulated insulin secretion, higher ghrelin secretion, hyperphagia,…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

In a recent paper by Perry et al., researchers describe an investigation into the putative mechanisms by which gut microbiota alterations may lead to obesity, insulin resistance, and metabolic syndrome. Authors describe increased production of acetate by altered gut microbiota in rats. They link this to activation of the parasympathetic nervous system, increased glucose-stimulated insulin secretion, higher ghrelin secretion, hyperphagia,…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

The International Scientific Association for Probiotics and Prebiotics, in its 15th year, held its 2016 Annual Meeting June 7th to 9th in Turku, Finland. Prof. Seppo Salminen, who has more publications on probiotics than any other researcher globally, was the local host. The program featured a broad cross-section of speakers and topics, a vibrant poster session comprising 32 abstracts from students…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

The International Scientific Association for Probiotics and Prebiotics, in its 15th year, held its 2016 Annual Meeting June 7th to 9th in Turku, Finland. Prof. Seppo Salminen, who has more publications on probiotics than any other researcher globally, was the local host. The program featured a broad cross-section of speakers and topics, a vibrant poster session comprising 32 abstracts from students…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

Childhood undernutrition affects millions of children worldwide and has long-term severe effects, which include stunted growth and impaired cognitive development, among others. A recent study, led by Dr. Jeffrey Gordon from the Centre for Genome Sciences and Systems Biology at Washington University School of Medicine in St. Louis (USA), found that gut bacteria could be considered a useful tool for…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Childhood undernutrition affects millions of children worldwide and has long-term severe effects, which include stunted growth and impaired cognitive development, among others. A recent study, led by Dr. Jeffrey Gordon from the Centre for Genome Sciences and Systems Biology at Washington University School of Medicine in St. Louis (USA), found that gut bacteria could be considered a useful tool for…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

In recent years, there is growing interest in alternative treatments for both inflammatory bowel disease and irritable bowel syndrome. Clinical trials are underway to test the potential of probiotics and their metabolic substrates, which are called prebiotics. The underlying principle is that the microbiome might be targeted by providing the metabolic fuel (prebiotics) needed for the growth and expansion of…

Stefan Jellbauer
Stefan Jellbauer is a Field Application Scientist in the Biotech industry. Previously, he was an ORISE fellow at the Food Safety division of the FDA and a Postdoc in Manuela Raffatellu’s lab at University of California, Irvine, where he studied host-pathogen interactions and mucosal immunology. He obtained his PhD in 2010 from Ludwig-Maximilians University in Munich, Germany.

In recent years, there is growing interest in alternative treatments for both inflammatory bowel disease and irritable bowel syndrome. Clinical trials are underway to test the potential of probiotics and their metabolic substrates, which are called prebiotics. The underlying principle is that the microbiome might be targeted by providing the metabolic fuel (prebiotics) needed for the growth and expansion of…

Stefan Jellbauer
Stefan Jellbauer is a Field Application Scientist in the Biotech industry. Previously, he was an ORISE fellow at the Food Safety division of the FDA and a Postdoc in Manuela Raffatellu’s lab at University of California, Irvine, where he studied host-pathogen interactions and mucosal immunology. He obtained his PhD in 2010 from Ludwig-Maximilians University in Munich, Germany.

When talking about irritable bowel syndrome [IBS], Dr. Eamonn Quigley eschews the term 'functional disorder'. For Quigley, a gastroenterologist and researcher at Houston Methodist Hospital (USA), it's only a matter of time before the disordered physiology of IBS becomes clear. "First of all, I think it’s a 'real' condition, one that we can recognize fairly readily, [even] given that there…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

When talking about irritable bowel syndrome [IBS], Dr. Eamonn Quigley eschews the term 'functional disorder'. For Quigley, a gastroenterologist and researcher at Houston Methodist Hospital (USA), it's only a matter of time before the disordered physiology of IBS becomes clear. "First of all, I think it’s a 'real' condition, one that we can recognize fairly readily, [even] given that there…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

As MyNewGut, a research initiative involving thirty organizations from fifteen countries, continued to carry out its research program on prebiotic fibres and the gut microbiota, project participants held a workshop before the International Dietary Fibre Conference 2015 in Paris. With presentations by well-known researchers, as well as industry and government representatives, the workshop brought together plans for updating and implementing…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

As MyNewGut, a research initiative involving thirty organizations from fifteen countries, continued to carry out its research program on prebiotic fibres and the gut microbiota, project participants held a workshop before the International Dietary Fibre Conference 2015 in Paris. With presentations by well-known researchers, as well as industry and government representatives, the workshop brought together plans for updating and implementing…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

The Third International Congress of Translational Research in Human Nutrition (ICTRHN) took place in Clermont-Ferrand, France, on June 26 & 27, 2015. This post is an overview of the final ICTRHN symposium on clinical implications. (See here and here for the rest of the GMFH coverage of ICTRHN.) Prof. Karine Clément, Institute of Cardiometabolism and Nutrition, France -- Microbiota in…

Fernando Aspiroz

The Third International Congress of Translational Research in Human Nutrition (ICTRHN) took place in Clermont-Ferrand, France, on June 26 & 27, 2015. This post is an overview of the final ICTRHN symposium on clinical implications. (See here and here for the rest of the GMFH coverage of ICTRHN.) Prof. Karine Clément, Institute of Cardiometabolism and Nutrition, France -- Microbiota in…

Fernando Aspiroz